Daiichi Sankyo at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Daiichi Sankyo brings 1 presentation to SABCS 2026 in San Antonio, and exhibits at Booth 343. The drugmaker's poster describes real-world treatment patterns in high-risk HER2-positive early breast cancer in the United States.
| Organization | SABCS 2026 Attendance |
|---|---|
Daiichi Sankyo Tokyo, Japan | |
Japanese drugmaker whose oncology portfolio centers on antibody-drug conjugates, including HER2- and TROP2-directed treatments used in breast cancer. | Booth Exhibiting at Booth 343 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Fri Dec 11 12:30–2pm |
Find decision makers at Daiichi Sankyo
Tell us what you sell and we’ll find the people at Daiichi Sankyo most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction